Now playing
01:26
How vaccines stop the spread of viruses
CNN
Now playing
02:13
Why losing weight might protect you from Covid-19
A selection of fruit ready to eat are displayed at a fruit and vegetable shop on April 12, 2016 in Lille, northern France. / AFP / DENIS CHARLET        (Photo credit should read DENIS CHARLET/AFP/Getty Images)
DENIS CHARLET/AFP/AFP/Getty Images
A selection of fruit ready to eat are displayed at a fruit and vegetable shop on April 12, 2016 in Lille, northern France. / AFP / DENIS CHARLET (Photo credit should read DENIS CHARLET/AFP/Getty Images)
Now playing
01:27
New diet can save lives and the planet, study says
this is your brain on pain health orig_00001025.jpg
CNN
this is your brain on pain health orig_00001025.jpg
Now playing
01:39
This is your brain on pain
Now playing
01:42
Here's why you can't stop eating pizza, ice cream and chocolate chip cookies
Now playing
01:10
Trouble sleeping? This may be why
CNN
Now playing
02:40
The reality of wine's health benefits
shutterstock
Now playing
01:49
These foods aren't as healthy as you think
Americans are still too fat according to a new study from JAMA. Two in three of Americans are registering as overweight or obese.
Shutterstock
Americans are still too fat according to a new study from JAMA. Two in three of Americans are registering as overweight or obese.
Now playing
01:15
What is obesity?
CNN
Now playing
01:17
Why your BMI matters
LONDON - MAY 16:  In this photo illustration a cigarette is seen burning on May 16, 2007 in London. Businesses and shops are gearing up for the introduction of the smoking ban on July 1 in England after similar bans have been introduced in Ireland, Scotland and Wales.  (Photo Illustration by Bruno Vincent/Getty Images)
Bruno Vincent/Getty Images Europe/Getty Images
LONDON - MAY 16: In this photo illustration a cigarette is seen burning on May 16, 2007 in London. Businesses and shops are gearing up for the introduction of the smoking ban on July 1 in England after similar bans have been introduced in Ireland, Scotland and Wales. (Photo Illustration by Bruno Vincent/Getty Images)
Now playing
01:07
What tobacco does to your health (2017)
Photo Illustration/Thinkstock
Now playing
01:12
World blood pressure rises (2016)
Woman pointing to area on mammogram x-ray, close-up
Getty Images/File
Woman pointing to area on mammogram x-ray, close-up
Now playing
01:19
Breast cancer: Know the facts
A surgeon sitting in front of screens of a Focal One device performs a robot-assisted prostate tumorectomy using ultrasound imaging on April 10, 2014 at the Edouard Herriot hospital in Lyon, center France. Focal One is the first robotic HIFU (high intensity focused ultrasound) device dedicated to the focal approach for prostate cancer therapy. According to EDAP TMS SA, a leader in therapeutic ultrasound, it combines the three essential components to efficiently perform a focal treatment: state-of-the-art imaging to localized tumors with the use of magnetic resonance imaging (MRI) combined with real-time ultrasound, utmost precision of robotic HIFU treatment focused only on identified targeted cancer areas, and immediate feedback on treatment efficacy utilizing Contrast-Enhanced Ultrasound Imaging. AFP PHOTO / JEFF PACHOUD        (Photo credit should read JEFF PACHOUD/AFP/Getty Images)
JEFF PACHOUD/AFP/AFP/Getty Images
A surgeon sitting in front of screens of a Focal One device performs a robot-assisted prostate tumorectomy using ultrasound imaging on April 10, 2014 at the Edouard Herriot hospital in Lyon, center France. Focal One is the first robotic HIFU (high intensity focused ultrasound) device dedicated to the focal approach for prostate cancer therapy. According to EDAP TMS SA, a leader in therapeutic ultrasound, it combines the three essential components to efficiently perform a focal treatment: state-of-the-art imaging to localized tumors with the use of magnetic resonance imaging (MRI) combined with real-time ultrasound, utmost precision of robotic HIFU treatment focused only on identified targeted cancer areas, and immediate feedback on treatment efficacy utilizing Contrast-Enhanced Ultrasound Imaging. AFP PHOTO / JEFF PACHOUD (Photo credit should read JEFF PACHOUD/AFP/Getty Images)
Now playing
01:21
What is prostate cancer?
Argosy
Now playing
00:53
What is Parkinson's disease?
Now playing
01:38
How Alzheimer's destroys the brain

Story highlights

The court considered a French man who developed multiple sclerosis one year after a hepatitis B vaccine

The decision is "illogical and confusing," experts say

(CNN) —  

The Court of Justice of the European Union ruled Wednesday that courts may consider vaccines to be the cause of an illness, even in the absence of scientific evidence confirming a link.

The EU’s highest court said that if the development of a disease is timely to the person’s receiving a vaccine, if the person was previously health with a lack of history of the disease in their family and if a significant number of disease cases are reported among people receiving a certain vaccine, this may serve as enough proof.

The ruling stemmed from the case of a French man known as J.W. who was vaccinated against hepatitis B in 1998 and developed multiple sclerosis a year later. Multiple sclerosis is a neurological disorder in which the body’s own immune system attacks the brain and spinal cord. The disease scars nerve tissue and causes a range of symptoms, from vision problems to paralysis. J.W. died in 2011.

I
n 2006, J.W. sued pharmaceutical company Sanofi Pasteur, which produced the vaccine, blaming it for his decline in health.

The case was brought before the Court of Appeal in France, which ruled that there was no scientific consensus supporting a causal link and no evidence of a causal link between the hepatitis B vaccine and the man’s multiple sclerosis, therefore dismissing the action.

This judgment was appealed and brought to the French Court of Cessation, which took it to the European Court of Justice.

The Court of Justice said that “specific and consistent evidence” relating to timeliness, a prior healthy status, lack of family history and multiple cases may prove to be enough, according to a statement. J.W.’s case referred to the first three criteria.

The ruling added that courts must ensure that evidence is “sufficiently serious, specific and consistent to warrant the conclusion,” having also considered available evidence and arguments made by a vaccine’s producer, to then decide that a vaccine is the most plausible explanation for any damage to health.

The court’s decision is not a ruling on J.W.’s case but provides guidance for all EU courts considering similar issues.

The EU court is authorizing national courts to make such judgments about causality themselves, based on evidence they are presented with, without reliance on expert opinion, said Professor Tony Fox from the pharmaceutical medicine group at King’s College London.

In a statement, a representative from Sanofi Pasteur said: “It is not our role to comment on this legal decision. However, Sanofi Pasteur wishes to reiterate that its vaccines are safe and effective and protect against infectious diseases. Our hepatitis B vaccines are safe and well tolerated. They have been approved by Health Authorities and are marketed for more than 30 years.”

The decision drew criticism from experts.

“No causal link exists” between the hepatitis B vaccine and multiple sclerosis, “but a few cases after vaccination would not be surprising, especially when administered to teenagers, just before the age of onset age for many MS sufferers,” said Keith Neal, emeritus professor in the epidemiology of infectious diseases at the University of Nottingham.

“What they are saying is, the vaccine is responsible for the patient’s MS if it can’t be proved it isn’t, and that is virtually impossible given what is worded. Potentially, this ruling affects all drugs and threatens the development of new drugs.”

Peter Openshaw, president of the British Society for Immunology and professor of experimental medicine at Imperial College London, said “it is very concerning that the European Court of Justice has ruled that judges can consider whether a vaccination led to someone developing a medical condition, even if there is no scientific evidence to support this.”

“The scientific evidence does not support a link between the hepatitis B vaccine, or any other vaccine in current use, and multiple sclerosis,” he said. “To say that there is a link between any vaccine and multiple sclerosis and at the same time to admit that there is no scientific evidence of such a link is illogical and confusing to the public.”

Join the conversation

  • See the latest news and share your comments with CNN Health on Facebook and Twitter.

The prior health of the patient, absence of family history and supposed close temporal relationship could all be coincidental, Fox said.

“The only alleged evidence that would be worth taking seriously is the alleged numbers of other similar cases,” he said. “Those data should be capable of detailed case comparisons for consistency, and probably also orthodox epidemiological study.”

But without such a study, Fox added, “one might just as well say, ‘If this vaccine causes MS, then why is it that millions of people have been vaccinated and did not get MS? And why are there so many people with MS who have never had this vaccination?’ “